Tg Therapeutics (TGTX) Non-Current Deffered Revenue (2012 - 2026)
Tg Therapeutics (TGTX) reported Non-Current Deffered Revenue of $14.53 million for Q2 2026, up 771.3% from $1.67 million a year earlier and up 111.6% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Non-Current Deffered Revenue (2012 - 2026) Analysis & Trends
At the end of FY2025, Tg Therapeutics posted Non-Current Deffered Revenue of $8.81 million, down 27.1% from FY2024.
- Non-Current Deffered Revenue has a five-year compound annual growth rate of 70.6% (FY2020 to FY2025).
- By year, Non-Current Deffered Revenue came in at $12.09 million in FY2024 (+100.9%), $6.02 million in FY2023, $305,000 in FY2022 (-33.3%) and $457,000 in FY2021 (-25.1%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Deffered Revenue since Q3 2024.
- Year over year, Non-Current Deffered Revenue gained in four of the last seven quarters, with growth averaging 121.2%.
- The high point for year-over-year Non-Current Deffered Revenue in five years was Q2 2026 (growth of 771.3%); the low point was Q2 2025 (a decline of 55.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.86 million (Q1 2026), $8.81 million (Q4 2025) and $8.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Tg Therapeutics | 8.21 Bn | 7.60 Bn | 199.14 Mn | 14.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.53 Mn |
| Mar 31, 2026 | 6.86 Mn |
| Dec 31, 2025 | 8.81 Mn |
| Sep 30, 2025 | 8.35 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | 12.09 Mn |
| Sep 30, 2024 | 16.17 Mn |
| Jun 30, 2024 | 3.74 Mn |
| Mar 31, 2024 | 3.24 Mn |
| Dec 31, 2023 | 6.02 Mn |
| Sep 30, 2023 | 190,000.00 |
| Jun 30, 2023 | 229,000.00 |
| Mar 31, 2023 | 267,000.00 |
| Dec 31, 2022 | 305,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Jun 30, 2022 | 381,000.00 |
| Mar 31, 2022 | 419,000.00 |
| Dec 31, 2021 | 457,000.00 |
| Sep 30, 2021 | 495,000.00 |
API Access
Tg Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();